Covered recipient · General Payments record
SEJAL JAYANTILAL PATEL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$3,200.85
- Reported across 155 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $509.34 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $215.89 | 13 |
| Novo Nordisk AS | $125.78 | 7 |
| VIVUS LLC | $62.95 | 3 |
| Currax Pharmaceuticals LLC | $31.55 | 2 |
| DEXCOM, INC. | $30.58 | 1 |
| Echosens North America, Inc. | $27.50 | 1 |
| ADC Therapeutics America, Inc. | $15.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ADC Therapeutics America, Inc. | $15.09 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121191133 | CMS |
| Currax Pharmaceuticals LLC | $16.67 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089525091 | CMS |
| Currax Pharmaceuticals LLC | $14.88 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089525093 | CMS |
| Dexcom, Inc. | $30.58 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153385886 | CMS |
| Echosens North America, Inc. | $27.50 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154982988 | CMS |
| Lilly USA, LLC | $15.08 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135943480 | CMS |
| Lilly USA, LLC | $20.47 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135943482 | CMS |
| Lilly USA, LLC | $15.16 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135863621 | CMS |
| Lilly USA, LLC | $18.43 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135863613 | CMS |
| Lilly USA, LLC | $21.84 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135944768 | CMS |
| Lilly USA, LLC | $6.64 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135944770 | CMS |
| Lilly USA, LLC | $16.91 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135906325 | CMS |
| Lilly USA, LLC | $15.85 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135863617 | CMS |
| Lilly USA, LLC | $15.25 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135887445 | CMS |
| Lilly USA, LLC | $15.17 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135949282 | CMS |
| Lilly USA, LLC | $14.96 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135962353 | CMS |
| Lilly USA, LLC | $20.49 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135935480 | CMS |
| Lilly USA, LLC | $19.64 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135887441 | CMS |
| Novo Nordisk Inc | $18.49 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100370591 | CMS |
| Novo Nordisk Inc | $19.66 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100602112 | CMS |
| Novo Nordisk Inc | $16.43 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100229592 | CMS |
| Novo Nordisk Inc | $14.01 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100482639 | CMS |
| Novo Nordisk Inc | $14.73 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100585248 | CMS |
| Novo Nordisk Inc | $21.97 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100547978 | CMS |
| Novo Nordisk Inc | $20.49 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100229904 | CMS |
| VIVUS LLC | $18.71 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129420817 | CMS |
| VIVUS LLC | $23.20 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129420819 | CMS |
| VIVUS LLC | $21.04 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129420821 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.